
The trial studied the efficacy of bamlanivimab and remdesivir on hospitalized COVID-19 patients - the same therapies given to President Trump. But researchers say people showed no marked improvement.
(Image credit: David Morrison/AP)

from News : NPR https://ift.tt/3kyGSqO
No comments:
Post a Comment